English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glucosamine/neoplasms

The link is saved to the clipboard
9 results

Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof

Only registered users can translate articles
Log In/Sign up
This application is the National Phase of PCT/KR2006/005229 filed on Dec. 6, 2006, which claims priority under 35 U.S.C. 119(a) to Patent Application Nos. 10-2006-0054519 and 10-2006-0119620 filed in Republic of Korea on Jun. 16, 2006 and Nov. 30, 2006, respectively. All of the above applications

Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy

Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD The present invention relates to the use of N-acetyl-D-glucosamine and pharmaceutical acceptable salts thereof in the manufacture of a medicament for inhibiting the side effect of radio-chemical therapy. BACKGROUND ART After accepting radio-chemical treatment, patients with neoplasm

Dietary supplement formulation for controlling inflammation and cancer

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin. BACKGROUND OF THE

N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity

Only registered users can translate articles
Log In/Sign up
Background of the Invention The present invention relates to acyl derivatives of glucosamines with amino acids or synthetic peptides, endowed with antitumor chemotherapeutic activity against transplanted tumors in animals, to pharmaceutical compositions containing said derivatives, to processes for

Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use

Only registered users can translate articles
Log In/Sign up
The present invention relates to specific glucosamine disaccharides, in particular to 2-N- and/or 2'-N-acylated glucosamine disaccharides, wherein at least one of the acyl groups is branched, and to compounds comprising these disaccharides. The present invention relates further to methods for

Composition for treating hormonally-dependent cancers

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary

N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention relates to N-acyl derivatives of an amino sugar with an oligopeptide, endowed with antitumor chemotherapeutic activity, and to pharmaceutical compositions containing said derivatives. Antitumor chemotherapy has been and still is an object of

Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid

Only registered users can translate articles
Log In/Sign up
This is a national-phase application of Int'l Appln. No. PCT/JP03/17030 under 35 U.S.C. 371, filed Dec. 26, 2003; the entire content of which is hereby incorporated by reference in this application. TECHNICAL FIELD The present invention relates to a novel nucleic acid, the nucleic acid for testing

Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to methods for discovering agonists and antagonists of the interaction between UDP-sugars (e.g.,UDP-glucose, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetyl glucosamine) and their cellular receptor, human KIAA0001 receptor. The invention also
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge